SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-174796
Filing Date
2022-06-15
Accepted
2022-06-15 16:30:34
Documents
12
Period of Report
2022-06-14
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d307287d8k.htm   iXBRL 8-K 35676
  Complete submission text file 0001193125-22-174796.txt   161887

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scph-20220614.xsd EX-101.SCH 2888
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scph-20220614_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scph-20220614_pre.xml EX-101.PRE 11729
6 EXTRACTED XBRL INSTANCE DOCUMENT d307287d8k_htm.xml XML 3461
Mailing Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803
Business Address 2400 DISTRICT AVENUE SUITE 310 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Filer) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38293 | Film No.: 221018110
SIC: 2834 Pharmaceutical Preparations